Authors:
Awan, T
Forloni, G
Ragg, E
Iussich, S
Rossi, G
Colombo, L
Girola, L
Massignan, T
Bugiani, O
Salmona, M
Tagliavini, F
Citation: T. Awan et al., Therapeutic approaches to prion diseases: In vitro studies with tetracycline compounds, ALZHEIMER'S DISEASE, 2001, pp. 809-820
Authors:
Tagliavini, F
Forloni, G
Colombo, L
Rossi, G
Girola, L
Canciani, B
Angeretti, N
Giampaolo, L
Peressini, E
Awan, T
De Gioia, L
Ragg, E
Bugiani, O
Salmona, M
Citation: F. Tagliavini et al., Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro, J MOL BIOL, 300(5), 2000, pp. 1309-1322
Authors:
Cerri, A
Almirante, N
Barassi, P
Benicchio, A
Fedrizzi, G
Ferrari, P
Micheletti, R
Quadri, L
Ragg, E
Rossi, R
Santagostino, M
Schiavone, A
Serra, F
Zappavigna, MP
Melloni, P
Citation: A. Cerri et al., 17 beta-O-aminoalkyloximes of 5 beta-androstane-3 beta,14 beta-diol with digitalis-like activity: Synthesis, cardiotonic activity, structure-activityrelationships, and molecular modeling of the Na+,K+-ATPase receptor, J MED CHEM, 43(12), 2000, pp. 2332-2349
Authors:
Ragg, E
Tagliavini, F
Malesani, P
Monticelli, L
Bugiani, O
Forloni, G
Salmona, M
Citation: E. Ragg et al., Determination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by H-1 NMR and restrained molecular dynamics, EUR J BIOCH, 266(3), 1999, pp. 1192-1201